Publication Date

All

Current year

Past 5 years

 


 

Subject Area
Health (94)
See all

Results in Health


94 results

Sort by date / relevance

The 2019-20 Budget: The Governor's Individual Health Insurance Market Affordability Proposals

Feb 7, 2019 - Under a state individual mandate, most or all of the individuals who otherwise would have not enrolled in Medi ‑Cal would still enroll, likely eliminating any reduced Medi ‑Cal costs otherwise associated with the end of the federal individual mandate penalty.
https://lao.ca.gov/Publications/Report/3927

The 2019-20 Budget: The Governor's Individual Health Insurance Market Affordability Proposals [Publication Details]

Feb 7, 2019 - The 2019-20 Budget: The Governor's Individual Health Insurance Market Affordability Proposals [Publication Details] Translate Our Website This Google ™ translation feature provided on the Legislative Analyst's Office (LAO) website is for informational purposes only.
https://lao.ca.gov/Publications/Detail/3927

The 2025-26 Budget: Health Care Access and Information

Feb 20, 2025 - With  key implementation details of the insulin initiative still uncertain, the Legislature likely will want to work with HCAI to better understand the continued need for these funds. If stronger justification is not forthcoming, the Legislature could redirect these funds for other one ‑time budget priorities or further defer them as needed.
https://lao.ca.gov/Publications/Report/4979

The 2025-26 California Spending Plan: Health

Oct 16, 2025 - The initiative also includes funds to explore other market interventions to reduce the cost of diapers. When the Governor first announced this proposal, HCAI estimated the funds would cover around 25  percent of newborn babies in 2025-26 and around 50  percent of newborn babies in 2026-27.
https://lao.ca.gov/Publications/Report/5075

Considering Medi-Cal in the Midst of a Changing Fiscal and Policy Landscape

Oct 24, 2025 - Magnitude of Costs Is Still Emerging. Though county costs from H.R.  1 are likely, the total effect across the state is uncertain. Counties and other stakeholders were still reviewing H.R.  1 ’s provisions and potential effects when we spoke to them earlier this year.
https://lao.ca.gov/Publications/Report/5083

Impact of COVID-19 on Health Care Access

May 7, 2021 - In more recent months, data from this survey show sustained declines in foregone or delayed care, although challenges in access to medical care likely remain given that the COVID-19 pandemic is still ongoing.
https://lao.ca.gov/Publications/Report/4426

The 2025-26 Budget: MCO Tax and Proposition 35

Feb 26, 2025 - This would shift some of the cost of the tax away from the federal government and onto the commercial market and California consumers. Proposition 35, however, limits the size of the tax on commercial enrollment.
https://lao.ca.gov/Publications/Report/4992

The 2022-23 Budget: Health Care Access and Affordability

Feb 23, 2022 - (For example, the inflation in nonmedical service sectors discussed above is still higher than overall inflation over the same time period.) Nevertheless, growth in health care costs is attributed at least in part to distinctive market conditions that particularly impact health care prices such as reduced competition among health care payers and providers due to mergers and acquisitions in the health care sector.
https://lao.ca.gov/Publications/Report/4560

The 2025-26 Budget: Understanding Recent Increases in the Medi-Cal Senior Caseload

Mar 6, 2025 - With regard to income, seniors and persons with disabilities still must have countable income below 138  percent of the FPL —$20,783 for an individual in 2025. In general, seniors and persons with disabilities with income over this threshold still can be eligible for Medi ‑Cal but must pay a share of cost.
https://lao.ca.gov/Publications/Report/5010

The 2025-26 Budget: Medi-Cal Pharmacy Spending

Apr 3, 2025 - In particular, a few decades ago, relatively expensive second ‑generation versions of these drugs (known as “atypical antipsychotics ”) entered the market. Over time, the initial brand drugs have lost their patent exclusivity and generic competitors have entered the market.
https://lao.ca.gov/Publications/Report/5026